NGL Fine-Chem Limited (NGLFINE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.056x

Based on the latest financial reports, NGL Fine-Chem Limited (NGLFINE) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs167.72 Million ≈ $1.81 Million USD) by net assets (Rs3.00 Billion ≈ $32.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NGL Fine-Chem Limited stock valuation for the company's overall valuation and market capitalisation.

NGL Fine-Chem Limited - Cash Flow Conversion Efficiency Trend (2009–2026)

This chart illustrates how NGL Fine-Chem Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NGL Fine-Chem Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NGL Fine-Chem Limited ranked by their cash flow conversion efficiency. Explore how high is NGL Fine-Chem Limited's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Franklin Universal Closed Fund
NYSE:FT
0.027x
Nam Kim Steel JSC
VN:NKG
0.062x
Lithium Royalty Corp
TO:LIRC
-0.001x
XRF Scientific Ltd
AU:XRF
0.104x
TerrAscend Corp
F:TED
0.081x
SPACSphere Acquisition Corp. Class A Ordinary Shares
NASDAQ:SSAC
0.000x
D2L Inc
TO:DTOL
-0.196x
Ascom Holding AG
SW:ASCN
0.200x

Annual Cash Flow Conversion Efficiency for NGL Fine-Chem Limited (2009–2026)

The table below shows the annual cash flow conversion efficiency of NGL Fine-Chem Limited from 2009 to 2026. View NGL Fine-Chem Limited stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs3.29 Billion
≈ $35.60 Million
Rs395.40 Million
≈ $4.28 Million
0.120x -5.31%
2025-03-31 Rs2.82 Billion
≈ $30.54 Million
Rs358.22 Million
≈ $3.87 Million
0.127x +62.77%
2024-03-31 Rs2.63 Billion
≈ $28.40 Million
Rs204.65 Million
≈ $2.21 Million
0.078x -50.85%
2023-03-31 Rs2.23 Billion
≈ $24.07 Million
Rs352.86 Million
≈ $3.82 Million
0.159x +133.07%
2022-03-31 Rs2.03 Billion
≈ $21.98 Million
Rs138.25 Million
≈ $1.50 Million
0.068x -61.59%
2021-03-31 Rs1.54 Billion
≈ $16.70 Million
Rs273.54 Million
≈ $2.96 Million
0.177x -14.36%
2020-03-31 Rs989.61 Million
≈ $10.70 Million
Rs204.64 Million
≈ $2.21 Million
0.207x +115.34%
2019-03-31 Rs921.23 Million
≈ $9.96 Million
Rs88.47 Million
≈ $956.76K
0.096x -69.07%
2018-03-31 Rs720.42 Million
≈ $7.79 Million
Rs223.65 Million
≈ $2.42 Million
0.310x +84.86%
2017-03-31 Rs585.12 Million
≈ $6.33 Million
Rs98.26 Million
≈ $1.06 Million
0.168x -11.71%
2016-03-31 Rs442.15 Million
≈ $4.78 Million
Rs84.10 Million
≈ $909.54K
0.190x -16.82%
2015-03-31 Rs328.16 Million
≈ $3.55 Million
Rs75.04 Million
≈ $811.54K
0.229x +1990.49%
2014-03-31 Rs245.44 Million
≈ $2.65 Million
Rs-2.97 Million
≈ $-32.11K
-0.012x -932.61%
2013-03-31 Rs200.15 Million
≈ $2.16 Million
Rs-234.46K
≈ $-2.54K
-0.001x -101.43%
2012-03-31 Rs171.06 Million
≈ $1.85 Million
Rs14.01 Million
≈ $151.47K
0.082x -66.15%
2011-03-31 Rs160.59 Million
≈ $1.74 Million
Rs38.85 Million
≈ $420.12K
0.242x +140.92%
2010-03-31 Rs136.48 Million
≈ $1.48 Million
Rs13.70 Million
≈ $148.20K
0.100x +413.97%
2009-03-31 Rs109.35 Million
≈ $1.18 Million
Rs-3.50 Million
≈ $-37.82K
-0.032x --

About NGL Fine-Chem Limited

NSE:NGLFINE India Drug Manufacturers - General
Market Cap
$184.95 Million
Rs17.10 Billion INR
Market Cap Rank
#16936 Global
#881 in India
Share Price
Rs2768.20
Change (1 day)
+1.95%
52-Week Range
Rs1278.80 - Rs3457.80
All Time High
Rs3457.80
About

NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosph… Read more